• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Pharma/Biotech Companies - In the News

For the discussion of current news articles in the pharma/biotech space. Please provide a link to the article, and do not cut and paste whole articles due to copyright restrictions.